ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling (2019)
Attributed to:
Precision medicine and the mutational landscape of high grade serous ovarian cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/767533
Publication URI: http://dx.doi.org/10.1101/767533
Type: Preprint